Treatment of Brain Oncology (Tumor, Cancer)

A diagnosis of brain tumor requires detailed consideration and a clear action plan. The main feature of the disease is its anatomical location. The brain is a structure confined to the limited space of the skull, where any tumor inevitably leads to compression of the surrounding tissues and impairment of their function.

At the K+31 Clinic in Moscow, patients with central nervous system oncology are treated using a multidisciplinary consultation. The decision on treatment strategy is made jointly by a team of neurosurgeons, oncologists, chemotherapists, and radiologists. This approach allows us to develop a personalized and most effective strategy for each patient.

Best
specialists
Expert
equipment
Advanced diagnostic
treatment
Sign up
Fill out the entry form on the page and we will call you back
Sign up Позвонить
Download the application “Personal Account K+31”
Everything about your health in one click!
Subscribe to social networks K+31
To keep up to date with current offers and receive useful advice about your health.

Definition and types of brain tumors

Any neoplasm is based on a pathological process in which a cell loses the ability to control its own division. As a result, a nodule of abnormal tissue—a neoplasm—forms.

The primary classification divides all intracranial pathological growths into two categories.

  • Primary. These are neoplasms that arise directly from brain structures—nerve cells, glia (supporting tissue), or the meninges. This group is the subject of neurooncology.
  • Secondary (metastases). In this case, we are not talking about primary brain cancer. These are lesions that form in the head as a result of the migration of malignant cells from a tumor located in another organ, for example, the lung. Treatment here will be comprehensive and focused primarily on the primary site of the disease.

The next step, which determines the treatment plan and prognosis, is histological verification of the tumor. It is necessary to determine whether it is benign or malignant.

Definition and types of brain tumors

Benign tumors

The term "benign" describes the biological properties of the tumor, but does not negate its clinical significance. Characteristics of such a neoplasm:

  • It has a slow growth rate
  • It has clear boundaries. The tumor does not invade the brain, but pushes it away as it grows.
  • Its cells are highly differentiated, meaning their structure is close to normal.

The clinical manifestations (main symptoms) of such a neoplasm are caused by the mass effect – pressure on functionally important areas of the brain. If the tumor is resectable, that is, accessible to a surgeon, the primary treatment method is total surgical removal. In many cases, this leads to a complete cure.

Malignant tumors

This group of tumors is what is more accurately called brain cancer. Their biological behavior is fundamentally different:

  • Rapid, infiltrative growth. This means that the tumor invades healthy brain tissue without clear boundaries. Imagine a drop of ink falling on a blotter.
  • Significant cellular atypia (cells are very different from normal)
  • High potential for recurrence – regrowth after treatment.

Malignant tumors require combination therapy. Treatment typically includes several methods: neurosurgery to safely remove as much of the visible tumor as possible, followed by radiation therapy and/or chemotherapy to target any remaining cancer cells. Accurate diagnosis and staging are crucial in planning all subsequent steps.

Causes and risk factors

The question every patient asks: Why did this happen to me? What is the cause? It must be acknowledged: in the vast majority of cases, a single, precise cause for a primary brain tumor cannot be determined. This is not a disease that can be directly linked to lifestyle or bad habits. The tumor's development is the result of a spontaneous genetic mutation in one of the cells. A random glitch.

However, medicine has identified a number of factors that can increase the risk of developing such tumors. It is important to understand that these are statistical correlations, not direct causes.

  • Ionizing radiation. High doses of radiation, especially those received in childhood (for example, during radiation therapy for another condition), have been shown to increase the risk of developing head tumors later in life. This is the most significant known risk factor.
  • Hereditary genetic syndromes. There are a number of rare inherited diseases, such as neurofibromatosis, Li-Fraumeni syndrome, and tuberous sclerosis. They significantly increase the risk of developing CNS tumors. However, they account for only a small percentage of all cases.
  • Age. The risk of developing most brain tumors increases with age. The peak incidence occurs in older people. However, some types of tumors (for example, medulloblastoma) are specific to childhood.
  • Immune deficiency. Patients with congenital or acquired immunodeficiency (for example, after organ transplantation or HIV infection) have a higher risk of developing certain tumors, particularly CNS lymphomas.

Cell phones, power lines, and head injuries—to date, there is no convincing scientific evidence confirming a link between these and brain cancer.

Symptoms of brain tumors

The clinical presentation, or set of symptoms, of brain tumors varies greatly. It depends on two main factors: the tumor's size and, more importantly, its location. All symptoms can be divided into two broad groups: general cerebral and focal.

General symptoms

These symptoms are a consequence of increased intracranial pressure. The growing tumor occupies a confined space within the skull, compressing the brain and disrupting the circulation of cerebrospinal fluid.

  • Headache. This is the most common symptom. But this is not a typical headache. The tumor is characterized by a dull, aching pain, often occurring in the morning and intensifying with coughing, sneezing, and straining. It is poorly relieved by conventional analgesics.
  • Nausea and vomiting. The classic symptom is vomiting at the peak of the headache, which does not bring relief. This is not caused by stomach problems, but by direct irritation of the vomiting center in the brain.
  • Dizziness and loss of balance. A feeling of unsteadiness and unsteadiness when walking.
  • Seizures. The sudden onset of an epileptic seizure in an adult who has never had one is a very alarming symptom that requires immediate diagnosis. [The text appears to be incomplete and likely a mistranslation.]
  • Disturbances in consciousness and mental state. Drowsiness, lethargy, behavioral changes, decreased memory and concentration. The patient becomes apathetic and indifferent.

Focal symptoms

These symptoms directly indicate which part of the brain is affected. They arise due to the destruction or compression of a specific functional center by the tumor.

  • Movement disturbances. Weakness in an arm or leg (paresis), up to complete paralysis.
  • Sensory disturbances. Numbness, tingling, a "pins and needles" sensation in the limbs or face.
  • Speech disturbances. The patient has difficulty finding words, their speech becomes slurred (motor aphasia). Or they stop understanding speech addressed to them (sensory aphasia).
  • Visual disturbances. Visual field loss (the person cannot see part of the space), double vision, decreased visual acuity.
  • Coordination disturbances. Failure to perform precise movements, clumsiness, and unsteadiness of gait (ataxia). This symptom often indicates a problem in the cerebellum.
  • Auditory and olfactory hallucinations. The appearance of extraneous sounds or odors that are not actually present.
  • Hormonal imbalances. This symptom is characteristic of tumors of the pituitary gland and hypothalamus.

The appearance of any of these symptoms, especially if they develop gradually and steadily progress, is an absolute indication for immediate medical attention and a comprehensive diagnosis.

Brain Cancer Stages

A common question from patients: what stage is my cancer? This requires clarification. The classic TNM (Tumor, Nodus, Metastasis) staging system, which is used to stage most cancers (for example, lung or colon), is rarely used for primary brain tumors. Why is this?

Firstly, primary brain cancer very rarely metastasizes beyond the central nervous system. Its aggressiveness manifests itself in local, infiltrative growth, destroying the tissue around it.

Secondly, even the smallest benign tumor, located, for example, in the brainstem, can be fatal. A large tumor in the frontal lobe, however, can remain asymptomatic for a long time. Size does not always determine the prognosis.

Therefore, neuro-oncology uses a different system—the Grade classification developed by the World Health Organization (WHO). It is based on the histological structure of the tumor, that is, how its cells appear under a microscope.

  • Grade I. These are benign tumors. The cells are almost normal and grow very slowly. With complete removal, the prognosis is excellent.
  • Grade II. The tumor is still considered conditionally benign or low-grade malignancy. The cells begin to deviate from the norm, growth is slow, but there is a tendency for infiltration and recurrence. Over time, such a tumor can progress to a higher grade of malignancy.
  • Grade III. This is clearly a malignant process. The cells are atypical, dividing actively. The tumor infiltrates the brain. The prognosis is grave.
  • Grade IV. The most aggressive stage. The cells are extremely atypical, growing very rapidly, and the tumor contains foci of necrosis (tissue death). An example is glioblastoma.

Determining the degree of malignancy (grade) is the primary diagnostic task. It is this grade, not the conventional "stage," that determines the choice of treatment strategy.

Diagnosis of brain tumors

Making an accurate diagnosis of a suspected brain tumor is a complex process. It requires the use of high-tech imaging techniques and, ultimately, obtaining a tissue sample for examination. A diagnosis of brain cancer cannot be made based on symptoms alone.

Diagnostic Methods

The foundation of modern brain tumor diagnostics is neuroimaging.

  • Magnetic resonance imaging (MRI). This is the "gold standard." MRI allows us to visualize the brain itself, its structures, membranes, and, ultimately, the tumor itself with exceptional accuracy. We can see its precise location, size, and relationship to important functional areas.
    • MRI with contrast. For better tumor visualization, a special gadolinium-based contrast agent is injected into a vein. Malignant tumors typically have a well-developed vascular network and actively accumulate contrast, becoming bright and "glowing" on the images. This helps distinguish them from benign tumors and other processes (for example, the consequences of a stroke).
  • Computed tomography (CT). CT better visualizes the bony structures of the skull. This method is often used in emergency situations to quickly rule out hemorrhage. For a detailed diagnosis of the tumor itself, CT is less informative than MRI.
  • Positron emission tomography (PET-CT). This is a functional imaging technique. The patient is injected with radioactive glucose. Cancer cells actively consume it, causing the tumor foci to glow on the images. PET-CT helps assess the degree of tumor malignancy and distinguish relapse from postoperative changes.

Examination and confirmation

MRI results provide a preliminary diagnosis. We can determine with a high degree of certainty the tumor type. But a definitive, 100% diagnosis can only be made one way: by obtaining a sample of tumor tissue and examining it under a microscope. This is called histological verification.

How can this be obtained?

  • Biopsy. If the tumor is located in a difficult-to-reach or functionally significant location, a stereotactic biopsy is performed. Using a special navigation system, the surgeon inserts a thin needle precisely into the tumor through a tiny opening in the skull and takes a small tissue sample.
  • During tumor removal surgery. If immediate surgery is planned, the tissue sample taken during surgery is sent for histological examination. Sometimes, a rapid analysis is performed during surgery so the surgeon can adjust the extent of the removal.

After examining the tissue, the pathologist makes a final diagnosis: the exact type of tumor and its grade. Only then can the correct and most effective treatment strategy be developed.

Treatment

Brain Tumor Treatment

The diagnosis has been confirmed. What's next? Brain tumor treatment is always a multi-stage process. There is no single "magic pill" or universal surgery. The choice of strategy depends on many factors:

  • The type and degree of tumor malignancy. This is the main factor. Benign meningioma and malignant glioblastoma will be treated very differently.
  • The location of the tumor. The tumor's accessibility to the surgeon and its proximity to vital brain centers (speech, motor) can dramatically change the treatment plan.
  • The size of the tumor and its spread.
  • The patient's general condition, age, and the presence of comorbidities.

Modern neuro-oncology in Moscow and worldwide rests on three pillars: surgery, radiation therapy, and chemotherapy. These methods are often combined. In recent years, new, high-tech approaches have been added to these.

Surgical Treatment

Surgical removal is the first and often most important step in the treatment of most brain tumors. The goals of surgery can vary.

Total Removal

If the tumor is benign and has clear borders (for example, a meningioma), the surgeon aims to remove it completely. In this case, surgery can lead to a complete cure.

Maximum Possible Safe Removal (Cytoreduction)

For malignant tumors that invade the brain, removing every last cell of the cancerous tissue is impossible—this will lead to severe neurological deficits. The surgeon's goal is to remove as much of the tumor as possible without damaging functionally significant areas. Why is this necessary? Firstly, it reduces the mass effect, that is, the pressure on the brain. The patient immediately feels better. Secondly, the smaller the residual tumor, the more effective subsequent radiation and chemotherapy will be.

Biopsy

If removal is impossible or impractical, the surgeon's task is simply to remove a piece of tissue for accurate diagnosis.

Modern neurosurgery is not a blind operation. We use a whole arsenal of technologies to make the operation as precise and safe as possible:

  • Neuronavigation. This is like GPS for the surgeon. MRI data is loaded into a computer, which creates a 3D model of the patient's head. During the operation, the system shows with extreme precision the position of the surgeon's instrument in relation to the tumor and important structures.
  • Intraoperative monitoring. During the operation, special sensors track the functions of nerves and areas of the cerebral cortex. If the surgeon's instrument approaches a critical area, the system triggers an alarm. This allows the tumor to be removed at the very border of the functional centers without damaging them.
  • Awake craniotomy. If the tumor is located in the speech or motor areas, part of the surgery can be performed with the patient awake. The patient is conscious, feels no pain (there are no pain receptors in the brain), and follows the neuropsychologist's commands (speaking, moving the arm). Meanwhile, the surgeon maps, or identifies, which areas on the surface of the brain are responsible for what, so they can be avoided.

Radiation Therapy

Radiation therapy (radiotherapy) uses high-energy ionizing radiation (X-rays) to destroy cancer cells and inhibit their division. It is the primary treatment for most malignant brain tumors.

It is usually prescribed after surgery to destroy any cancer cells that the surgeon was unable to remove. In some cases, if surgery is not possible, radiation therapy may be the primary treatment.

Modern devices (linear accelerators) allow the radiation dose to be delivered very precisely to the tumor, minimizing exposure to healthy brain tissue. Treatment typically lasts several weeks, with daily sessions.

Chemotherapy

Chemotherapy is the use of drugs that kill rapidly dividing cells or slow their growth. The problem is that between the blood and the brain there is a barrier called the blood-brain barrier (BBB). This dense filter protects the brain from toxins, but it also prevents most chemotherapy drugs from penetrating tumor tissue.

Therefore, only a small number of drugs that can penetrate this barrier are used to treat brain tumors. The most well-known of these is Temozolomide (Temodal). It is often prescribed simultaneously with radiation therapy and as a maintenance regimen afterward.

Targeted Therapy

A more modern and "smart" type of drug treatment. Targeted drugs target specific molecular targets present in cancer cells and responsible for their growth and division. Before prescribing this treatment, a specialized genetic analysis of the tumor tissue is performed. If the desired "target" is found, the patient can be prescribed the targeted drug. An example is Bevacizumab (Avastin), which blocks the growth of new vessels in the tumor, depriving it of nutrients.

Robotic Radiosurgery

This is not a surgical method in the strict sense. The knife here is not a scalpel, but rather radiation beams. Systems such as the Gamma Knife or CyberKnife deliver a very high, destructive dose of radiation precisely to the tumor in one or more sessions, with minimal impact on surrounding healthy tissue. This method is ideal for treating:

  • Small, deep-seated benign tumors
  • Solitary brain metastases
  • Residual tumor or recurrence after surgery

Palliative Care

When brain cancer is in an advanced stage and radical treatment is no longer possible, palliative care becomes the primary focus. Its goal is not to cure the disease, but to maximize the patient's quality of life: relieve pain, reduce brain swelling with steroids, and control seizures and other severe symptoms. This is a crucial part of oncology, aimed at preserving a person's dignity at all stages of the disease.

Prognosis and Survival

The prognosis for a brain tumor diagnosis is one of the most complex issues. It is highly individual. No two patients and no two tumors are alike. The prognosis is influenced by key factors:

  • Histological type and grade of malignancy. This is the most important. The prognosis for a patient with a benign meningioma (Grade I) and a glioblastoma (Grade IV) will be dramatically different.
  • Molecular genetic tumor markers. Today, we know that even tumors of the same type behave differently depending on the presence of certain mutations.
  • Extent of surgical resection. The more completely the tumor is removed, the better the prognosis.
  • Age and general condition of the patient. Young patients with a good somatic status tolerate treatment better.
  • Tumor response to therapy. The effectiveness of radiation and chemotherapy also plays a huge role.

Prevention and Rehabilitation

There is no specific prevention for primary brain tumors, as the exact cause is unknown in most cases.

Rehabilitation is a crucial stage of treatment. After surgery or radiation therapy, patients may experience motor, speech, or cognitive impairments. The goal of the rehabilitation team is to help restore lost functions as much as possible. This includes speech therapists, physical therapists, occupational therapists, and neuropsychologists.

When to see a doctor

A brain tumor isn't a condition you can easily miss if you're paying attention. You should immediately consult a neurologist or primary care physician if you experience the following symptoms, especially if they appear out of the blue and worsen over time:

  • Unexplained, persistent headache, especially in the morning
  • First-ever epileptic seizure
  • Weakness or numbness in an arm or leg
  • Speech, vision, or coordination problems
  • Sudden changes in behavior, memory, or thinking

Timely diagnosis is the key to successful treatment.

When to see a doctor

Frequently Asked Questions

Can brain cancer be cured?

Some types of tumors, especially benign ones, can be completely cured with surgical removal. For malignant tumors, the goal of treatment is to achieve long-term remission and maximize quality of life.

Is brain surgery painful?

Brain tissue itself has no pain receptors. The surgery is performed under general anesthesia, making it completely painless. Postoperative pain in the incision area is usually moderate and well controlled with medication.

Does hair loss occur during brain tumor treatment?

Hair loss can occur in the treated area during radiation therapy. During chemotherapy, hair loss depends on the specific drug, but brain tumor treatments often use regimens that do not cause total alopecia.

Bibliography

  1. The textbook "Oncology" edited by V.I. Chissov and S.L. Daryalova, published by GEOTAR-Media in 2007.
  2. Neurology. National Guidelines. Brief Edition / edited by E.I. Gusev, A.N. Konovalov, A.B. Gekht. - Moscow: GEOTAR-Media, 2018. - 688 p. - ISBN 978-5-9704-4405-4.
  3. Sashin, D.V. Dissertation: Diagnostic Methods and Characteristics of Brain Tumors / D.V. Sashin. — Moscow: NMIC Oncology, 2020.
  4. Personalized Treatment of Brain Gliomas: Targeted Therapy, Patient-Specific Tumor Models (Review) / K.S. Yashin, D.V. Yuzhakova, D.A. Sachkova, L.S. Kukhnina, T.M. Kharitonova, A.S. Zolotova, I.A. Medyanik, M.V. Shirmanova – Article // Standards and Technologies of Medicine. – 2023. – No. 3.

Our doctors

Merkulov Igor Alexandrovich
Experience 33 years
Make an appointment
Merkulov
Igor Alexandrovich
Deputy Chief Physician for Oncology, Oncologist
Ershova Ksenia Igorevna
Experience 22 years
Make an appointment
Ershova
Ksenia Igorevna
Head of department, oncologist
Abashin Sergey Yuryevich
Experience 42 years
Make an appointment
Abashin
Sergey Yuryevich
Head of oncology projects, oncologist
Kalakutskaya Natalia Lvovna
Experience 27 years
Make an appointment
Kalakutskaya
Natalia Lvovna
Doctor-oncologist
Rasner Pavel Ilyich
Experience 31 year
Make an appointment
Rasner
Pavel Ilyich
Consultant in urology, urologist
Malygin Sergey Evgenyevich
Experience 30 years
Make an appointment
Malygin
Sergey Evgenyevich
Oncologist-mammologist, surgeon
Pshikhachev Ahmed Mukhamedovich
Experience 22 years
Make an appointment
Pshikhachev
Ahmed Mukhamedovich
Urologist, Oncologist
Shevchuk Alexei Sergeyevich
Experience 25 years
Make an appointment
Shevchuk
Alexei Sergeyevich
Oncogynecology consultant, obstetrician-gynecologist
Chichkanova Tatyana Vladimirovna
Experience 24 years
Make an appointment
Chichkanova
Tatyana Vladimirovna
Oncologist-mammologist, radiologist
Ovsiy Oksana Gennadievna
Experience 13 years
Make an appointment
Ovsiy
Oksana Gennadievna
Doctor-oncologist
Katz Ksenia Vladimirovna
Experience 11 years
Make an appointment
Katz
Ksenia Vladimirovna
Dermatovenerologist, oncologist
Korshikova Kamila Mukhtorovna
Experience 4 years
Make an appointment
Korshikova
Kamila Mukhtorovna
Radiotherapist
Ter-Arutyunyants Svetlana Andreevna
Experience 26 years
Make an appointment
Ter-Arutyunyants
Svetlana Andreevna
Radiotherapist, oncologist
Udin Oleg Ivanovich
Experience 31 year
Make an appointment
Udin
Oleg Ivanovich
Deputy chief physician for surgery, surgeon
Kogonia Lali Mikhailovna
Experience 51 year
Make an appointment
Kogonia
Lali Mikhailovna
Chemotherapist
Volkova Daria Mikhailovna
Experience 16 years
Make an appointment
Volkova
Daria Mikhailovna
Head of the Department of Radiation Therapy, Radiotherapist
Gomov
Mikhail Alexandrovich
Consultant in oncogynecology, obstetrician-gynecologist
Menkes (Ryabova) Yulia Alexandrovna
Experience 4 years
Make an appointment
Menkes (Ryabova)
Yulia Alexandrovna
Oncologist-chemotherapist
Grishin Igor Igorevich
Experience 32 years
Make an appointment
Grishin
Igor Igorevich
Obstetrician-gynecologist
Achba Maya Otarovna
Experience 17 years
Make an appointment
Achba
Maya Otarovna
Radiologist, ultrasound diagnostician, oncologist-mammologist
Lukyanenko Vladimir Alexandrovich
Experience 17 years
Make an appointment
Lukyanenko
Vladimir Alexandrovich
Oncologist-mammologist
Volenko Ivan Alexandrovich
Experience 14 years
Make an appointment
Volenko
Ivan Alexandrovich
Surgeon-oncologist-mammologist, plastic surgeon
Dubinina Yulia Nikolaevna
Experience 12 years
Make an appointment
Dubinina
Yulia Nikolaevna
Oncologist
Khailova Maria Sergeevna
Experience 4 years
Make an appointment
Khailova
Maria Sergeevna
Oncologist
Peshkova Marina Sergeevna
Experience 2 years
Make an appointment
Peshkova
Marina Sergeevna
Oncologist
Yakovleva Yana Sergeevna
Experience 7 years
Make an appointment
Yakovleva
Yana Sergeevna
Radiotherapist
Leira Railevna Akhmetova
Experience 2 years
Make an appointment
Leira
Railevna Akhmetova
Radiotherapist
Ivanova Olga Vladimirovna
Experience 25 years
Make an appointment
Ivanova
Olga Vladimirovna
Radiotherapist
Akhmerov Radmir Damirovich
Experience 10 years
Make an appointment
Akhmerov
Radmir Damirovich
Oncologist, obstetrician-gynecologist, plastic surgeon
Magdiev Arslan Khulatdaevich
Experience 13 years
Make an appointment
Magdiev
Arslan Khulatdaevich
Surgeon, oncologist, phlebologist
Morozova Albina Soslanovna
Experience 17 years
Make an appointment
Morozova
Albina Soslanovna
Acting head of the department of antitumor drug therapy, oncologist
Batukhtina Elena Viktorovna
Experience 24 years
Make an appointment
Batukhtina
Elena Viktorovna
Surgeon, oncologist
Iluridze Georgy Davidovich
Experience 8 years
Make an appointment
Iluridze
Georgy Davidovich
Oncologist, traumatologist-orthopedist, surgeon
Alferov Anton Sergeevich
Experience 15 years
Make an appointment
Alferov
Anton Sergeevich
Urologist, andrologist
Gabaraev Alan Petrovich
Experience 12 years
Make an appointment
Gabaraev
Alan Petrovich
Urologist, andrologist
All specialists
2GIS Award
2GIS Award

This award is given to clinics with the highest ratings according to user ratings, a large number of requests from this site, and in the absence of critical violations.

«Good place» according to Yandex
«Good place» according to Yandex

This award is given to clinics with the highest ratings according to user ratings. It means that the place is known, loved, and definitely worth visiting.

Our doctors are laureates of the ProDoctors Award
Our doctors are laureates of the ProDoctors Award

The ProDoctors portal collected 500 thousand reviews, compiled a rating of doctors based on them and awarded the best. We are proud that our doctors are among those awarded.

Make an appointment at a convenient time on the nearest date

News

20 june 2025 year
Possibilities of re-irradiation in case of recurrent glioblastoma
Author: Volkova Daria Mikhailovna, radiotherapist, head of the radiation therapy department of K31 City.
22 january 2025 year
Briefly about sarcomas in patients with Lynch syndrome
Khailova Maria Sergeevna, oncologist, Department of Antitumor Drug Therapy, K31 City.
17 january 2025 year
Perspective: More than a conference

Our head of the radiation therapy department, Daria Mikhailovna Volkova, recently returned from the conference "Prospect is more than a conference" in Kazan. There she represented our clinic K+31, sharing her experience and knowledge.

At the conference, Daria Mikhailovna gave a report on the topic: "Clinical case of CRT in unresectable NSCLC".

27 december 2024 year
A new approach to the treatment of soft tissue sarcomas
Sarcomas are a rare and heterogeneous group of malignant tumors: less than 1% of all malignant neoplasms in adults. Such a rare occurrence of this nosology makes it difficult to conduct large-scale studies, so each positive result of scientific work is worth its weight in gold.
17 december 2024 year
Ipilimumab with nivolumab in molecularly selected patients with castration-resistant prostate cancer
Metastatic castration-resistant prostate cancer (mCRPC) is commonly resistant to immune checkpoint inhibitors (ICIs).
01 december 2024 year
Results of the round table K+31 West “Non-oncological problems of cancer patients”
The K+31 West Clinic held a scientific and practical conference that brought together leading experts in the field of oncology, gynecology, radiotherapy, cardiology and other areas. The event discussed modern approaches to the diagnosis and treatment of oncological diseases, as well as issues of interdisciplinary interaction.
29 november 2024 year
177Lu-PSMA-617 versus androgen axis inhibitor in the treatment of taxane-naïve advanced metastatic castration-resistant prostate cancer
Prostate-specific membrane antigen (PSMA) is a well-studied cell membrane antigen specific for prostate cancer (PCa) and is not found in other tissues of the body.
09 november 2024 year
Are the long-term oncologic outcomes different between neoadjuvant chemotherapy and adjuvant chemotherapy in locally advanced breast cancer?
Today's post is prompted by the question: "Is there a difference in cancer outcomes depending on the sequence of chemotherapy and surgery?"
26 october 2024 year
Neoadjuvant therapy with nivolumab + relatlimab or nivolumab + ipilimumab in triple-negative breast cancer
In triple-negative breast cancer (TNBC), the addition of immunotherapy to neoadjuvant chemotherapy improves pathological complete response (pCR) rates...
13 october 2024 year
Breakthrough in oncology: treatment of metastatic melanoma with the drug "Nurdati"
Recently, a young patient with a relapse of metastatic melanoma came to the K+31 West clinic. After successful remission on targeted drugs, the disease made itself felt again. An important task arose - to choose a new approach to treatment...
07 october 2024 year
The influence of progesterone receptor levels on prognosis in patients with advanced breast cancer
A CDK4/6 inhibitor in combination with endocrine therapy is the standard first-line therapy for patients with advanced hormone-receptor-positive (HR) breast cancer...
07 october 2024 year
VII International Forum of Oncology and Radiotherapy “For Life – For Life”
The forum is a significant event in the oncology industry, the oncologist, radiotherapist of the K+31 Clinic - Svetlana Andreevna Ter-Arutyunyants spoke.
27 september 2024 year
Hematological toxicity of chemotherapy in patients with breast and ovarian cancer
BRCA1 and BRCA2 are tumor suppressor genes that play a central role in repairing double-stranded DNA breaks through homologous recombination, a fundamental DNA repair process that maintains genome integrity and, in particular, prevents possible tumor transformation of cells. Defects and mutations in these genes significantly increase the risk of developing cancer of various organs. According to some data, the prevalence of pathogenic variants in these genes in the Russian population is 1:300 for the BRCA1 gene and 1:800 for the BRCA2 gene.
17 september 2024 year
Real-World Outcomes of Lenvatinib and Anti-PD-1 Therapy in Patients With Advanced Melanoma
There are currently no treatment options for patients with advanced melanoma who have failed immunotherapy or targeted therapy.
20 august 2024 year
K+31 West held a special excursion for high school students from the “First Movement” together with RUDN University
Our future doctors saw the international level of medical services, looked into the radiology department, where cancer is treated according to world standards, and learned about advanced diagnostic methods.
15 august 2024 year
Preoperative iron supplementation is better for treating iron deficiency anemia
Iron administration is associated with a significant reduction in 30-day postoperative mortality and morbidity compared with red blood cell transfusion
11 august 2024 year
How to apply for oncology treatment under compulsory medical insurance in Moscow: instructions
According to Russian law, citizens of the country can receive medical care in the event of detection of an oncological disease at the expense of the compulsory medical insurance, and patients from the regions can apply for treatment in Moscow.
07 august 2024 year
Oncology news digest 04.08.2024
Amivantamab plus Lasertinib versus Osimertinib for first-line treatment of EGFR-mutated advanced NSCLC.
04 august 2024 year
Oncology news digest 07/21/2024

Long-term results of adjuvant therapy with dabrafenib and trametinib in stage III melanoma. COMBI-AD study.

21 july 2024 year
Oncology news digest 07/07/2024
Neoadjuvant nivolumab and ipilimumab for resectable stage III melanoma
07 july 2024 year
Oncology news digest 30.06.2024
A randomized, double-blind, placebo-controlled, phase II trial of oxybutynin versus placebo for the treatment of hot flashes in men receiving androgen deprivation therapy.
30 june 2024 year
Effect of Omega-3 Fatty Acid Diet on Prostate Cancer Progression
Involvement of tumor-associated macrophages and GPR120 dependence in the tumor microenvironment.
27 june 2024 year
The right to quality of life: K+31 hosted a round table for doctors on pain management in cancer patients

Top experts from K+31 and other clinics discussed a personalized approach to the assessment and treatment of pain in cancer patients.

29 may 2024 year
Obesity and the risk of developing cancer: what is the impact of body mass index, risks and features

Obesity is a chronic disease characterized by excessive accumulation of fatty tissue in the body.

15 march 2024 year
Thyroid cancer: types, symptoms, treatment methods

Formations (so-called nodes) in the thyroid gland are often benign in nature, however, they require regular monitoring. It is important to carry out additional studies in a timely manner (including a biopsy of suspicious nodes) in order to diagnose cancer in a timely manner. process and begin appropriate treatment.

14 march 2024 year
How to diagnose pancreatic cancer in the early stages: first symptoms and diagnostic methods

Oncopathology of this type is complicated by the location of the affected organ. Carrying out the operation requires high qualifications specialist and is often dangerous to the patient’s health. In addition, it is difficult to diagnose the disease at an early stage. not always, since the pathology develops over many years asymptomatically, and the appearance of the first signs may already indicate stage 3 or 4.

05 march 2024 year
Malignant bone tumors - symptoms, diagnosis, modern methods of therapy

Bone tumor is a collective name for malignant and benign tumors that affect skeletal bone tissue (bone or cartilage). Malignant bone tumors are called sarcomas.

02 march 2024 year
What is epidural anesthesia?

This type of anesthesia has become widely known due to its use in obstetrics and gynecology, as it is widely used to facilitate labor.

01 march 2024 year
Stomach cancer: symptoms, modern methods of diagnosis and therapy

In order to timely detect and effectively eliminate oncological pathology, it is recommended to undergo regular examinations and be observed by specialists if there is discomfort in the gastrointestinal tract.

14 february 2024 year

Price

Reception
Price
Primary oncologist appointment
from 5 900 ₽
Repeated appointment with an oncologist
from 5 900 ₽

To get a consultation

Fill out the form, our managers will contact you within 15 minutes

Reviews 9

Maya is super professional and very careful
15.11.2025
Ts. Natalia Yuryevna

About doctor:

Achba Maya Otarovna

I was admitted to the radiation therapy department after receiving a referral from the hospital for a stereotactic liver procedure. Before coming to your clinic, I had visited two other hospitals. At both, the doctors didn't even fully examine the CT disc and immediately agreed to perform the procedure. At the first, the doctor said they would hold a consultation, but only to complete the paperwork. The consultation refused, even though this same doctor was the only radiologist present. At the second, the head of the department, also without properly examining the CT scan, said he would remove the lesions in one session. Then I read the reviews... I was terrified. Then my attending physicians at the hospital (very good and caring) took matters into their own hands and discovered that there is a NAME in radiation therapy, and specifically in stereotactic liver surgery, in Moscow. It was Volkova from K+31. After dealing with empty spaces and medical scams, I had given up hope and was simply shocked. Darya Mikhailovna requested an MRI and carefully and thoroughly reviewed the CT and MRI scans. She planned the schedule. I attended the sessions for two weeks. There were no delays. The nursing staff is not only friendly and caring with patients, they are competent, and they offer helpful tips that they should know, but, unfortunately, in most clinics, they don't. The atmosphere in the department is amazing. Warmth, hope, professionalism, and a genuine interest in each patient. All of this is thanks to Darya Mikhailovna. Due to my illness, I visit many medical institutions, both free and private. I encounter arrogant, extremely unqualified, and simply not very smart doctors, and poorly trained, bordering on rude nursing staff. Unfortunately, it's all over the place. For the first time in many years, I've found a department whose director is not only a talented, highly qualified specialist, but also an excellent leader. Darya Mikhailovna is constantly at work. I've been managing intelligent people for many years, and I see that Volkova and the entire staff never waste a minute of their time. At the same time, you can always ask a question to Darya Mikhailovna, who is incredibly busy, and receive not a standard answer, but thoughtful, meaningful answers. I agree with the opinion of Moscow doctors and express the opinion of a patient. Volkova is a NAME. A doctor and a manager. And, unfortunately, a rare case among Moscow doctors. I would like to point out that today K+31 is perhaps one of the very few Moscow clinics where the quality of work of both doctors and nursing staff far exceeds that of other clinics.
24.10.2025
D. Ekaterina Yuryevna
A very sensitive and comfortable doctor
07.10.2025
G. Anna Alexandrovna

About doctor:

Achba Maya Otarovna

Excellent doctor, everything went as comfortably as possible!
04.10.2025
K. Arina Uruzmagovna

About doctor:

Achba Maya Otarovna

The doctor is a professional, that's clear right away. I'll definitely come back to him for my health.
01.10.2025
Sch. Irina Gennadievna
I express my deepest, most sincere gratitude to the K+31 clinic and personally to its highly skilled surgeon, Oleg Ivanovich Yudin! I want to share my amazing experience of treatment at your clinic. I had a gallbladder removal, and the results exceeded all my expectations. Oleg Ivanovich, you are a magician! Your professionalism, calm confidence, and attentive attention to all my questions before the surgery completely dispelled any fears. Thank you for your golden hands and sensitive heart. I especially want to highlight your unique approach to anesthesia. I couldn't have imagined such a gentle anesthesia! I woke up easily, without any unpleasant consequences. And the most incredible thing is that just two hours after the surgery, I was fully conscious, feeling great, and already participating in an online meeting! For me, this is the main indicator of the precision work of the entire team. A huge thank you to all the medical staff in the surgical department: the attentive and kind nurses, anesthesiologists, and orderlies. You surrounded me with such care that my hospital stay felt more like a vacation. I can't help but mention the amazing conditions in the ward: modern equipment, cleanliness, comfort, and attention to detail create an atmosphere that in itself promotes recovery. And, of course, thank you to the department managers and administrators. You are always available, and all issues are resolved quickly, efficiently, and with unfailing kindness. K+31 Clinic is an impeccable standard of medicine, where the patient, their comfort, and their health come first. I recommend you to everyone I know and wish you prosperity with all my heart!
30.09.2025
K. Julia

About doctor:

Udin Oleg Ivanovich

Good afternoon! I would like to express my sincere gratitude to Oleg Ivanovich Yudin, an excellent surgeon, highly qualified professional, and kind person. I would also like to thank Anton Ivanovich Grechin for his professionalism and attentiveness. Managers Yulia and Ekaterina effectively assist their colleagues and patients, and I thank them. Sincerely, S.I.
29.09.2025
S.I.
I trust Dr. Malygin, and this is the most important thing for a patient.
28.09.2025
A. Zarema Asulovna
I would like to express my sincere gratitude to Dr. Oleg Ivanovich Yudin (the operating surgeon) and Dr. Tigran Grachyaevich Dzavayal, as well as the clinic staff, for the surgery and the high level of medical care provided. The organization of the work deserves special praise: the doctors checked on my condition several times daily, explained everything in detail, and created an atmosphere of confidence. The rooms are modern, comfortable, and clean, with all the necessary amenities. I thank you for your professionalism and attentive care of your patients.
24.09.2025
U. Irina Viktorovna
Write a review
Почему К+31?
К + 31 — full-cycle multidisciplinary medical centers, including the possibility of providing medical services of European quality level.
К + 31 — are leading doctors and diagnostics using high-tech equipment from world manufacturers (Karl Storz, Olympus, Siemens, Toshiba, Bausch&Lomb, Technolas, Zeiss, Topcon).
К + 31 — is ethical. The staff of K+31 clinics maintain open relationships with patients and partners. An individual approach to each patient is the basis of our service standards.
К + 31 — is modernity. On call 24/7: call center operators will answer your questions at any time and book you an appointment with doctors. Contact us by phone, through the feedback form on the website and WhatsApp.

Our clinics

K+31 on Lobachevskogo

st. Lobachevskogo, 42/4

+7 499 999-31-31

Subway
1
11
Prospect Vernadsky Station
By a car
Lobachevsky, we pass the first barrier (security post of the City Clinical Hospital No. 31), turn right at the second barrier (security post K+31)
Parking pass
Opening hours
Mon-Fri: 08:00 – 21:00
Saturday: 09:00 – 19:00
Sunday: 09:00 – 18:00
K+31 Petrovskie Vorota

1st Kolobovsky pereulok, 4

74999993131

Subway
9
Tsvetnoy Bulvar
10
Trubnaya
By a car
Moving along Petrovsky Boulevard, turn onto st. Petrovka, right after - on the 1st Kolobovsky per. Municipal parking
Opening hours
Mon-Fri: 08:00 – 21:00
Sat-Sun: 09:00 – 19:00
K+31 West

Orshanskaya, 16/2; Ak. Pavlova, 22

74999993131

Subway
3
Molodezhnaya
By a car
Moving along Orshanskaya street, we turn to the barrier with the guard post K+31. You do not need to order a pass, they will open it for you
Opening hours on holidays

01.11: 09:00—20:00

02.11—04.11: 09:00—18:00

Didn't find the service you were looking for?

Экстренная помощь